Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
37.5M
-
Number of holders
-
6
-
Total 13F shares, excl. options
-
1M
-
Shares change
-
-9.56K
-
Total reported value, excl. options
-
$1.02M
-
Value change
-
-$19.9K
-
Number of buys
-
1
-
Number of sells
-
-3
-
Price
-
$1.03
Significant Holders of OKYO Pharma Ltd - Common (OKYO) as of Q3 2024
8 filings reported holding OKYO - OKYO Pharma Ltd - Common as of Q3 2024.
OKYO Pharma Ltd - Common (OKYO) has 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1M shares
of 37.5M outstanding shares and own 2.67% of the company stock.
Largest 8 shareholders include BARCLAYS PLC (961K shares), CITADEL ADVISORS LLC (14.9K shares), Cerity Partners LLC (12.8K shares), GEODE CAPITAL MANAGEMENT, LLC (12.1K shares), UBS Group AG (525 shares), Continuum Advisory, LLC (50 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares), and HSBC HOLDINGS PLC (0 shares).
This table shows the top 6 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.